Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services ...

Explore the impact of 3D models in drug discovery and how they enhance predictive insights in pre-clinical research.

CDR-Life today announced the presentation of data for its novel T cell engager (TCE) programs at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago. The presentations ...

Positive IND-enabling data on MP0712 targeting DLL3, the most advanced Radio-DARPin program in co-development with Orano Med, entering clinical development in 2025 First preclinical data of novel targ ...

Over the last decade there has been a move to reduce the amount of preclinical work requiring the use of sentient animals.

Highlights from Prelude’s efforts to discover and develop selective KAT6A degraders, including preclinical data, demonstrating potential for a differentiated efficacy and safety profile ...

OP-3136 showed activity that was independent of KAT6 amplification or over expression. In the OVCAR3 model, OP-3136 monotherapy demonstrated sustained tumor regression across the 28-day study period ...

A rice-sized microrobot offers precision in brain surgery, starting with tumor biopsies in a first clinical trial set for ...

Pancreatic cancer is a leading cause of cancer-related death, with a five-year survival rate of 13%. The high mortality is ...

Bayer and Vividion Therapeutics to present latest research on their advancing oncology portfolio at AACR 2025 annual meeting: Berlin, Germany Wednesday, April 23, 2025, 10:00 Hrs ...